John Poulos
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
John Poulos currently works at Faron Pharmaceuticals Oy, as Independent Non-Executive Director from 2017, Memgen, Inc., as Director from 2020, and GNK Advisors, Inc., as President from 2016.
Mr. Poulos also formerly worked at Abbott Pharmaceutical, Inc., as Head-Pharmaceutical Licensing & Acquisitions from 2005 to 2012 and AbbVie Oy, as VP, Head-Business Development & Acquisitions from 2013 to 2016.
Mr. Poulos received his undergraduate degree and Masters Business Admin degree from Indiana University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FARON PHARMACEUTICALS OY | Directeur/Membre du Conseil | 16/05/2017 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Directeur/Membre du Conseil | 18/11/2020 |
GNK Advisors, Inc. | President | 01/01/2016 |
| Sociétés | Poste | Fin |
|---|---|---|
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Corporate Officer/Principal | 01/01/2016 |
Abbott Pharmaceutical, Inc. | Corporate Officer/Principal | 01/01/2012 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Health Technology |
Abbott Pharmaceutical, Inc. | |
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
GNK Advisors, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national